{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:22:25Z","timestamp":1790479345579,"version":"4.1.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.7147","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:31:11Z","timestamp":1547811071000},"page":"e187147","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France"],"prefix":"10.1001","volume":"2","author":[{"given":"Marie Joelle","family":"Jabagi","sequence":"first","affiliation":[{"name":"University of Paris Sud, Paris-Saclay University, Paris, France"},{"name":"Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Vey","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, CNRS, Inserm, Institut Paoli-Calmettes, Hematology Department, CRCM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Goncalves","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, CNRS, Inserm, Institut Paoli-Calmettes, Medical Oncology Department, CRCM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien","family":"Le Tri","sequence":"additional","affiliation":[{"name":"Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[{"name":"Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France"},{"name":"Versailles Saint-Quentin-en-Yvelines University, Montigny-Le-Bretonneux, AP-HP H\u00f4pital Sainte Perine Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[{"name":"Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"issue":"3","key":"zoi180298r1","first-page":"531","article-title":"Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.","volume":"72","author":"Curtis","year":"1984","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi180298r2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2013.54.6119","article-title":"Risk of marrow neoplasms after adjuvant breast cancer therapy: the National Comprehensive Cancer Network experience.","volume":"33","author":"Wolff","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi180298r3","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1002\/ajh.v90.5","article-title":"Characteristics and outcome of therapy-related myeloid neoplasms: report from the Italian network on secondary leukemias.","volume":"90","author":"Fianchi","year":"2015","journal-title":"Am J Hematol"},{"issue":"7","key":"zoi180298r4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","article-title":"Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi180298r5","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/sj.bjc.6603172","article-title":"Multiple primary tumours in women following breast cancer, 1973-2000.","volume":"94","author":"Raymond","year":"2006","journal-title":"Br J Cancer"},{"issue":"8","key":"zoi180298r6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2007.11.9081","article-title":"Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.","volume":"26","author":"Schaapveld","year":"2008","journal-title":"J Clin Oncol"},{"issue":"15","key":"zoi180298r7","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","article-title":"Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.","volume":"121","author":"Morton","year":"2013","journal-title":"Blood"},{"issue":"21","key":"zoi180298r8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood.V122.21.829.829","article-title":"Survival improvement of secondary acute myeloid leukemia over time: experience from 962 patients included in 13 EORTC-Gimema-HOVON Leukemia Group Trials.","volume":"122","author":"Suciu","year":"2013","journal-title":"Blood"},{"key":"zoi180298r9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1471-2407-11-260","article-title":"Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.","volume":"11","author":"Kaplan","year":"2011","journal-title":"BMC Cancer"},{"issue":"18","key":"zoi180298r10","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1200\/JCO.2005.05.029","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.","volume":"23","author":"Praga","year":"2005","journal-title":"J Clin Oncol"},{"issue":"17","key":"zoi180298r11","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"zoi180298r12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jama.2017.21269","article-title":"Association of hysteroscopic vs laparoscopic sterilization with procedural, gynecological, and medical outcomes.","volume":"319","author":"Bouillon","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi180298r13","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3026(15)00027-7","article-title":"Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.","volume":"2","author":"Bouillon","year":"2015","journal-title":"Lancet Haematol"},{"issue":"10","key":"zoi180298r14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamasurg.2015.1325","article-title":"Association between total hip replacement characteristics and 3-year prosthetic survivorship: a population-based study.","volume":"150","author":"Colas","year":"2015","journal-title":"JAMA Surg"},{"key":"zoi180298r15","doi-asserted-by":"publisher","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"issue":"10125","key":"zoi180298r17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"9324","key":"zoi180298r19","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"9114","key":"zoi180298r20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials.","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","journal-title":"Lancet"},{"issue":"17","key":"zoi180298r21","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1200\/JCO.2003.04.576","article-title":"Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.","volume":"21","author":"Goldhirsch","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9497","key":"zoi180298r22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(05)67657-X","article-title":"Breast cancer.","volume":"366","author":"Ronckers","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"zoi180298r23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.respe.2015.12.017","article-title":"Cancer incidence in France over the 1980-2012 period: Hematological malignancies.","volume":"64","author":"Le Guyader-Peyrou","year":"2016","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"31","key":"zoi180298r24","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study.","volume":"33","author":"Granfeldt \u00d8stg\u00e5rd","year":"2015","journal-title":"J Clin Oncol"},{"key":"zoi180298r25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/0284186X.2015.1115124","article-title":"Trends in hematological cancer in the elderly in Denmark, 1980-2012.","volume":"55","author":"Ocias","year":"2016","journal-title":"Acta Oncol"},{"issue":"1","key":"zoi180298r27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/annonc\/mdn530","article-title":"Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers.","volume":"20","author":"Beadle","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"zoi180298r28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1200\/JCO.2006.05.9048","article-title":"Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.","volume":"25","author":"Le Deley","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi180298r29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0360-3016(01)02661-X","article-title":"Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.","volume":"52","author":"Galper","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"zoi180298r30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.breast.2005.11.007","article-title":"Increased risk of acute myeloid leukaemia after treatment for breast cancer.","volume":"15","author":"Renella","year":"2006","journal-title":"Breast"},{"issue":"1","key":"zoi180298r31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1200\/JCO.1989.7.1.21","article-title":"Leukemia risk following radiotherapy for breast cancer.","volume":"7","author":"Curtis","year":"1989","journal-title":"J Clin Oncol"},{"issue":"26","key":"zoi180298r32","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"issue":"5","key":"zoi180298r33","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"2","key":"zoi180298r34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajh.23605","article-title":"Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.","volume":"89","author":"Ornstein","year":"2014","journal-title":"Am J Hematol"},{"issue":"7","key":"zoi180298r35","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"issue":"6","key":"zoi180298r36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/sj.leu.2402918","article-title":"High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.","volume":"17","author":"Ishizawa","year":"2003","journal-title":"Leukemia"},{"issue":"4","key":"zoi180298r37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1046\/j.1365-2141.1999.01636.x","article-title":"Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia: Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto.","volume":"106","author":"Pagano","year":"1999","journal-title":"Br J Haematol"},{"issue":"16","key":"zoi180298r38","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/cncr.26735","article-title":"Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis.","volume":"118","author":"Abdulwahab","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"zoi180298r39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat Res"},{"issue":"3","key":"zoi180298r40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","article-title":"Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.","volume":"114","author":"Andersen","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"zoi180298r41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjh.2015.170.issue-1","article-title":"Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy.","volume":"170","author":"Ganzel","year":"2015","journal-title":"Br J Haematol"},{"issue":"20","key":"zoi180298r42","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi180298r43","doi-asserted-by":"publisher","first-page":"e019264","DOI":"10.1136\/bmjopen-2017-019264","article-title":"Accuracy of administrative databases in detecting primary breast cancer diagnoses: a systematic review.","volume":"8","author":"Abraha","year":"2018","journal-title":"BMJ Open"},{"issue":"8","key":"zoi180298r44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer.","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi180298r45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer.","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"zoi180298r16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized Linear Models","author":"McCullagh","year":"1989","edition":"2nd ed"},{"key":"zoi180298r18","unstructured":"Institut National Du Cancer. Le cancer du sein - Les cancers les plus fr\u00e9quents. http:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Les-chiffres-du-cancer-en-France\/Epidemiologie-des-cancers\/Les-cancers-les-plus-frequents\/Cancer-du-sein. Accessed March 29, 2018."},{"key":"zoi180298r26","unstructured":"National Cancer Institute. Cancer stat facts: leukemia. https:\/\/seer.cancer.gov\/statfacts\/html\/leuks.html. Accessed March 29, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2720919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T14:41:22Z","timestamp":1573742482000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.7147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7147","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]}}}